Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Telix Pharmaceuticals has entered letters of intent to collaborate with EDAP TMS and Profound Medical, leaders in minimally invasive and image-guided ablative technologies for prostate cancer. The partnerships aim to explore the use of Telix's PSMA-PET imaging agents to support patient selection, treatment planning, and monitoring in emerging prost…